172 results
Page 7 of 9
8-K
EX-99.1
4fadmuzoy5au1xf
2 May 19
Other Events
7:10am
8-K
EX-99.1
9mzjzkqh
2 Apr 19
Other Events
8:10am
8-K/A
EX-99.1
k1yk9dx8 z0g28462d
27 Feb 19
CORRECTING and REPLACING — Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
5:16pm
8-K
EX-99.1
a6yul 32r4t7w4
27 Feb 19
Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
7:43am
8-K
EX-99.1
jsqsgzzs3n opq
7 Jan 19
Other Events
7:40am
8-K
EX-99.1
dese1qvgixuwj9o2
12 Dec 18
Adaptimmune Announces that Gwen Binder will leave in January 2019
8:39am
8-K
EX-99.1
r84 y4uw2a
6 Nov 18
Adaptimmune Reports Third Quarter 2018 Financial Results and Business Update
7:36am
8-K
EX-99.1
vz9m 8zdz
22 Oct 18
Other Events
8:38am
8-K
EX-99.1
91pzzelaeh
7 Sep 18
Adaptimmune Therapeutics plc Announces Closing of Registered Direct Offering of American Depositary Shares
12:00am
8-K
EX-99.1
6oz999rgtxthrg
15 Aug 18
Third Dosing Cohort to be initiated in MAGE-A4 SPEAR T-cell Basket Study After Favorable Review of Safety from One Billion Cell Dose Cohort
7:39am
8-K
EX-99.1
xrf90qr
2 Aug 18
Adaptimmune Reports Second Quarter 2018 Financial Results and Business Update
7:41am
8-K
EX-99.1
46dj3y
24 Jul 18
GSK and Adaptimmune Complete Transition of NY-ESO SPEAR T-cell Therapy Program to GSK
7:36am
8-K
EX-99.1
bgh2h68b ypkpda
18 Jul 18
Other Events
5:01pm
8-K
EX-99.1
7nde7w56
9 May 18
Adaptimmune Reports First Quarter 2018 Financial Results and Business Update
7:39am